OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 10/20/2023
Week ended 10/20/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 10/20/2023
- The Most Interesting M&A Deal of the Week:
- On October 18, 2023, FARMACEUTICALRX (Private), a vertically integrated competitor in Ohio and Pennsylvania, completed its acquisition of Body & Mind’s (BAMM: CSE) Ohio dispensary (NMG OH 1)
- The consideration includes $8.23M in upfront cash and contingent payments of $2.50M for each additional dispensary license granted to the subsidiary.
- The sale allows BAMM to reduce its interest expense by approximately $1M annually and concentrate on its Illinois and New Jersey retail assets.
- FARMACEUTICALRX is well positioned to gain from the likely conversion to adult rec and the potential for adult use in Pennsylvania
Week ended 10/20/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.